0.9403
price up icon5.25%   0.0469
 
loading
Renovorx Inc stock is traded at $0.9403, with a volume of 110.52K. It is up +5.25% in the last 24 hours and down -26.54% over the past month. RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
See More
Previous Close:
$0.8934
Open:
$0.9
24h Volume:
110.52K
Relative Volume:
0.59
Market Cap:
$34.39M
Revenue:
-
Net Income/Loss:
$-9.16M
P/E Ratio:
-1.6496
EPS:
-0.57
Net Cash Flow:
$-8.75M
1W Performance:
-1.59%
1M Performance:
-26.54%
6M Performance:
-8.71%
1Y Performance:
-3.07%
1-Day Range:
Value
$0.882
$0.95
1-Week Range:
Value
$0.80
$0.98
52-Week Range:
Value
$0.75
$1.6899

Renovorx Inc Stock (RNXT) Company Profile

Name
Name
Renovorx Inc
Name
Phone
408-800-2649
Name
Address
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Name
Employee
10
Name
Twitter
Name
Next Earnings Date
2024-08-15
Name
Latest SEC Filings
Name
RNXT's Discussions on Twitter

Compare RNXT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RNXT
Renovorx Inc
0.9403 34.38M 0 -9.16M -8.75M -0.57
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Renovorx Inc Stock (RNXT) Latest News

pulisher
Aug 20, 2025

Chartists Watching For Breakout in RenovoRx Inc.2025 Market Overview & Real-Time Volume Surge Alerts - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Annual Global Investment Conference in New York City, September 8-10, 2025 - Business Wire

Aug 20, 2025
pulisher
Aug 20, 2025

RenovoRx Inc. Breakout Confirmed by Volume MetricsMarket Activity Recap & Accurate Buy Signal Alerts - thegnnews.com

Aug 20, 2025
pulisher
Aug 19, 2025

Buy Rating Affirmed for RenovoRx Amid Promising Phase 3 Study Progress and Potential Stock Catalyst - TipRanks

Aug 19, 2025
pulisher
Aug 19, 2025

RenovoRx, Inc. (NASDAQ:RNXT) Q2 2025 Earnings Call Transcript - MSN

Aug 19, 2025
pulisher
Aug 18, 2025

Trend Dashboard Flags RenovoRx Inc. As Potential Swing TradeJuly 2025 Action & Fast Moving Market Watchlists - 선데이타임즈

Aug 18, 2025
pulisher
Aug 18, 2025

RenovoRx's Promising Product Launch and Strategic Expansion Drive Analyst's Buy Rating - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

RenovoRx Inc. Rebound Backed by Sentiment ShiftJuly 2025 Chart Watch & Reliable Intraday Trade Alerts - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

RenovoRx’s Promising Product Launch and Strategic Expansion Drive Buy Rating - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

RenovoRx Earnings Miss Highlights Short-Term Volatility, Signals Longer-Term Recovery Potential - AInvest

Aug 18, 2025
pulisher
Aug 17, 2025

RenovoRx (RNXT.O) Plummets 22.9%—What’s Behind the Sudden Drop? - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

RenovoRx Q2 Earnings Miss Sparks Immediate Sell-Off, But Long-Term Backtest Suggests Recovery Potential - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

Does RenovoRx Inc. have consistent dividend growth2025 Short Interest & High Yield Stock Recommendations - sisa-n.com

Aug 17, 2025
pulisher
Aug 17, 2025

What the charts say about RenovoRx Inc. todayTrade Entry Summary & High Yield Equity Trading Tips - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Backtesting results for RenovoRx Inc. trading strategiesJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Can trapped investors hope for a rebound in RenovoRx Inc.Dividend Hike & Technical Buy Zone Confirmation - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Price momentum metrics for RenovoRx Inc. explainedTrade Signal Summary & Real-Time Stock Price Movement Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What indicators show strength in RenovoRx Inc.2025 Key Highlights & Detailed Earnings Play Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What makes RenovoRx Inc. stock price move sharplyTrade Entry Summary & Scalable Portfolio Growth Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation - simplywall.st

Aug 16, 2025
pulisher
Aug 16, 2025

What data driven models say about RenovoRx Inc.’s futureSell Signal & Free Safe Capital Growth Stock Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will RenovoRx Inc. price bounce be sustainable2025 AllTime Highs & Stepwise Trade Signal Implementation - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is RenovoRx Inc. stock bottoming outTrade Risk Summary & Long-Term Safe Investment Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Visual trend scoring systems applied to RenovoRx Inc.Gap Up & Smart Allocation Stock Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

RenovoRx Revenue Jumps 28 Percent in Q2 - sharewise.com

Aug 16, 2025
pulisher
Aug 16, 2025

RenovoRx’s PanTheR Registry Trial: A Promising Update for Investors - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

Why RenovoRx Inc. stock attracts strong analyst attentionLong Setup & Target Return Focused Stock Picks - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

Is this a good reentry point in RenovoRx Inc.Global Markets & Reliable Intraday Trade Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Reports Strong Q2 2025 Revenue Growth - The Globe and Mail

Aug 15, 2025
pulisher
Aug 15, 2025

Machine Learning Models Forecast RenovoRx Inc. UptickWeekly Trade Report & Daily Profit Focused Stock Screening - beatles.ru

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Plummets 22.8% Intraday: Is This a Catalyst-Driven Collapse or a Buying Opportunity? - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Exceeds Revenue Estimates with $422,000 Q2 2025 Earnings, Net Loss Widens to $2.9 Million - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Reports Q2 2025 Revenue Growth, TIGeR-PaC Trial Continues with Positive Recommendation - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

How to recover losses in RenovoRx Inc. stock2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Inc (RNXT) Q2 2025 Earnings Call Highlights: Strong Market Demand and Strategic Trials ... - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Reports Commercial Revenue Growth in the Second Quarter 2025 and Announces Positive Independent Data Monitoring Committee Recommendation to Continue Pivotal Phase III TIGeR-PaC Trial Based on Interim Data Review - BioSpace

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx Reports Revenue Growth and Trial Progress - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

RenovoRx (RNXT): Navigating Short-Term Losses for Long-Term Oncology Breakthroughs - AInvest

Aug 15, 2025
pulisher
Aug 14, 2025

RenovoRx Inc. Added to High Probability Setup List2025 Market Overview & Daily Stock Trend Watchlist - metal.it

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: RenovoRx Q2 2025 reveals revenue challenges By Investing.com - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx earnings beat, revenue fell short of estimates By Investing.com - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: RenovoRx Q2 2025 reveals revenue challenges - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx earnings beat, revenue fell short of estimates - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Using Ichimoku Cloud for RenovoRx Inc. technicalsQuarterly Trade Review & Reliable Breakout Forecasts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Moving Average Crossover Confirms Uptrend in RenovoRx Inc.2025 Geopolitical Influence & AI Powered Market Entry Ideas - thegnnews.com

Aug 14, 2025
pulisher
Aug 14, 2025

Using data filters to optimize entry into RenovoRx Inc.Options Play & Fast Gain Stock Trading Tips - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Will RenovoRx Inc. continue its uptrendJuly 2025 Institutional & High Conviction Buy Zone Picks - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Can swing trading help recover from RenovoRx Inc. lossesMarket Movers & AI Enhanced Execution Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will RenovoRx Inc. continue its uptrend [Market Performance Recap]Community Trade Idea Sharing - Newser

Aug 13, 2025

Renovorx Inc Stock (RNXT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Renovorx Inc Stock (RNXT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Marton Laurence
Director
May 02 '25
Option Exercise
0.15
20,480
3,072
66,164
Agah Ramtin
Chief Medical Officer
Apr 15 '25
Buy
0.90
15,000
13,500
1,113,460
Bagai Shaun
Chief Executive Officer
Apr 15 '25
Buy
0.91
7,500
6,821
320,040
Agah Ramtin
Chief Medical Officer
Apr 11 '25
Buy
0.80
20,000
16,000
1,098,460
Kocak Ron
VP Controller and PAO
Apr 10 '25
Buy
0.79
6,500
5,135
12,595
Kocak Ron
VP Controller and PAO
Apr 09 '25
Buy
0.80
6,000
4,800
6,095
Kocak Ron
VP Controller and PAO
Apr 08 '25
Buy
0.80
95
76
95
Agah Ramtin
Chief Medical Officer
Apr 09 '25
Buy
0.81
30,000
24,399
1,078,460
Bagai Shaun
Chief Executive Officer
Apr 09 '25
Buy
0.83
10,000
8,300
312,540
Marton Laurence
Director
Apr 08 '25
Buy
0.85
12,050
10,218
45,684
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):